As of the latest Form 4 filed Jun 25, 2026.
What Neuropace Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Newest filing first — the 18 most recent filings for NPCE.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-25 | 2026-06-24 | Morrell Martha CHIEF MEDICAL OFFICER | FTax | −335.00 | $16.22 | $5.43K | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-19 | Kumar Rakhi Director | AAward | +989.00 | $15.63 | $15.5K | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-19 | Geiger Uri Director | AAward | +789.00 | $15.63 | $12.3K | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-19 | Fischer Frank M Director | AAward | +1.47K | $15.63 | $22.9K | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-05 | Kumar Rakhi Director | AAward | +2.89K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-05 | Ryan Renee Director | AAward | +2.89K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-05 | Huennekens R Scott Director | AAward | +2.89K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-05 | Andrade Lisa Director | AAward | +2.89K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-05 | Geiger Uri Director | AAward | +2.89K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-05 | Fischer Frank M Director | AAward | +2.89K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-04 | 2026-06-03 | Becker Joel CHIEF EXECUTIVE OFFICER | FTax | −1.25K | $15.88 | $19.9K | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-27 | Morrell Martha CHIEF MEDICAL OFFICER | FTax | −358.00 | $17.06 | $6.11K | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-27 | Becker Joel CHIEF EXECUTIVE OFFICER | FTax | −1.13K | $17.06 | $19.2K | No | Form 4 ↗ |
| 2026-03-25 | 2026-03-24 | Morrell Martha CHIEF MEDICAL OFFICER | FTax | −1.34K | $13.27 | $17.8K | No | Form 4 ↗ |
| 2026-03-24 | 2026-03-20 | Geiger Uri Director | AAward | +913.00 | $13.00 | $11.9K | No | Form 4 ↗ |
| 2026-03-24 | 2026-03-20 | LACOB JOSEPH Director | AAward | +865.00 | $13.00 | $11.2K | No | Form 4 ↗ |
| 2026-03-23 | 2026-03-20 | Kumar Rakhi Director | AAward | +1.15K | $13.00 | $15.0K | No | Form 4 ↗ |
| 2026-03-23 | 2026-03-20 | Fischer Frank M Director | AAward | +1.83K | $13.00 | $23.7K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also NPCE’s full analysis or the market-wide insider trading feed. The tabs above jump to NPCE’s other SEC data.
Source: SEC Form 4 filings for NPCE, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.